Vblt

Biogenics Ltd

-NasdaqGM
Prev Close: 6.85
Open: 6.75
Bid: 6.22 x 1000
Ask: 8.50 x 500
1y Target Est: 13.00
Beta: N/A
Next Earnings Date:
Day's Range: 6.30 - 6.86
52wk Range: 3.09 - 17.02
Volume: 115, 447
Avg Vol (3m): 899, 502
Market Cap: 128.03M
P/E (ttm):
EPS (ttm): -1.48
Div & Yield: N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • FPMI Trades At An 80 Percent Discount to Fair Value with Major Catalyst LoomingCompany Spotlight(Wed, Jun 17)
  • PVH rallies after hours on earnings beatat MarketWatch(Mon, Jun 1)
  • 6 Key Cancer Winners From ASCO Presentationsat 24/7 Wall St.(Mon, Jun 1)
  • Vascular Biogenics shares surge after news of positive trial of brain tumor treatmentat MarketWatch(Mon, Jun 1)
  • VBL Therapeutics Reports Updated Interim Results From Phase 2 Clinical Trial of VB-111 in Recurrent Glioblastoma (rGBM)GlobeNewswire(Mon, Jun 1)
  • VBL Therapeutics to Present Phase 1/2a Data From VB-111 in Recurrent Platinum-Resistant Mullerian Cancer at the 2015 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswire(Sat, May 30)
  • Vascular Biogenics Shares Could Doubleat Barrons.com(Tue, May 26)
  • VBL Therapeutics to Webcast Analyst and Investor Event at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2015GlobeNewswire(Tue, May 26)
  • Vascular Biogenics (VBLT) Shares March Higher, Can It Continue? - Tale of the TapeZacks(Fri, May 22)
  • Coverage initiated on VBL Therapeutics by ROTH CapitalBriefing.com(Fri, May 22)
  • Today's Volatility Alerts: What To Expect Next?Accesswire(Fri, May 15)
  • The 5 Winners and Losers From ASCO Presentationsat 24/7 Wall St.(Thu, May 14)
  • VBL Therapeutics to Present Positive Phase 1/2 Data for VB-111 in Recurrent Platinum-Resistant Mullerian Cancer at ASCO Annual MeetingGlobeNewswire(Wed, May 13)
  • Vascular Biogenics Ltd Earnings Call scheduled for 8:30 am ET todayCCBN(Tue, May 12)
  • Vascular Biogenics reports 1Q lossAP(Tue, May 12)

The broker you select will become the default broker for Trade Now

Key Statistics

Forward P/E (1 yr):
P/S (ttm):
Ex-Dividend Date:

Analysts

Annual EPS Est (Dec-15) : -0.78
Quarterly EPS Est (Jun-15) : -0.17
Mean Recommendation*: 2.5
PEG Ratio (5 yr expected):
Interesting facts
Related video
Vascular Biogenics Ltd. (VBLT) Stock Chart Technical
Vascular Biogenics Ltd. (VBLT) Stock Chart Technical ...
VBLT | Vascular Biogenics Ltd. | Video Chart for 6/1/15
VBLT | Vascular Biogenics Ltd. | Video Chart for 6/1/15
Careline Careline 50ml Bio Genic Active Cell Protection Night Cream 35+
Beauty (Careline)
  • Careline
  • Night Cream
  • Cell Protection
Related Posts